ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Salvianolic acid A alleviates cardiovascular injury in rats with chronic kidney disease by activating the PI3K/Akt/Nrf2/HO-1 and SIRT1/TLR4/ NF-κB/P38 signaling pathways

Wu, Chengkai; He, Bosai; Wang, Xiao; Zou, Yang; Ma, Ruixin; Gu, Yanting; Huang, Jian; Li, Songping; Wang, Jinhui; Wang, Jiahong哈尔滨医科大学
Journal of Functional Foods2023-11DOI: 10.1016/j.jff.2023.105861
24阅读
引用收藏
分享

摘要

Salvianolic acid A (Sal A), extracted from Danshen, has proven efficacy in preventing cardiovascular diseases. However, its effect on mitigating vascular damage caused by chronic kidney disease remains unclear. This study investigated the therapeutic effects and underlying mechanisms of Sal A in a rat model of 5/6 Nephrectomized (5/6Nx). The results of our study showed that Sal A effectively reduced the levels of kidney injury markers. Histopathological analysis revealed that Sal A dose-dependently attenuated arterial injury. The attenuation was characterized by the thinning of vascular endothelium and reduced endothelial cell hyperplasia, accompanied by decreased expression of OPN and C-Reaction Protein (CRP). Further investigations revealed that Sal A alleviated oxidative stress-induced vascular injury by activating the Phosphoinositide 3-kinase (PI3K)/Protein Kinase B (Akt)/Nuclear factor erythroid2-related factor 2(Nrf2)/Heme Oxygenase 1(HO-1) signaling pathway. Furthermore, Sal A inhibited inflammation by suppressing the Sirtuin-1(SIRT1)/Toll-like receptor 4(TLR4)/Nuclear factor kappa-B(NF-kappa B)/P38 signaling pathway and reducing the expression of pro-inflammatory cytokines. Our oxidative stress and inflammation cell models also supported these findings. In conclusion, Sal A treatment effectively attenuated vascular injury in 5/6Nx rats and exerted dual antioxidant and anti-inflammatory effects.

学科与关键词

关键词
Salvianolic acid AChronic kidney diseaseCardiovascular diseaseOxidative stressInflammation
相关
加载中…
  • Salvianolic Acid A Improves Rat Kidney Injury by Regulating MAPKs and TGF-β1/Smads Signaling Pathways
    Diao, Hai-Yang; Zhu, Wei; Liu, Jie; Yin, Sheng; Wang, Jin-Hui; Li, Chun-Li*MOLECULES, 2023, 28(8): 3630.被引 4
  • Exploring anti-acute kidney injury mechanism of Dahuang-Gancao decoction by network pharmacology and experimental validation
    Wang, Rui; An, Yi; Xu, Yifang; Li, Chengyin; Wang, Qiyuan; Zou, Yinshui*; Wang, Guangzhi*Aging-US, 2023, 15(19): 10072-10087.
  • Exploring anti-acute kidney injury mechanism of Dahuang-Gancao decoction by network pharmacology and experimental validation
    Wang, Rui; An, Yi; Xu, Yifang; Li, Chengyin; Wang, Qiyuan; Zou, Yinshui*; Wang, Guangzhi*Aging-US, 2023, 15(19): 10072-10087.
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Functional Foods
发表日期
2023-11
卷期
第 110 卷
页码
105861
DOI
10.1016/j.jff.2023.105861
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Founda-tion of China [81803769]; Young and Middle Aged Teacher-s ' Career Development Support Project of Shenyang Pharmaceutical University; Liao Ning Revitalization Talents Program [No.XLYC1902048]; National Science and Technology Major Project of the Ministry of Science and Technology of China [2018ZX09735005]

作者

  • W

    Wu, Chengkai (第一作者)

    shenyang pharmaceut univ

  • H

    He, Bosai

    shenyang pharmaceut univ

查看全部 10 位作者收起作者
  • W

    Wang, Xiao

    shenyang pharmaceut univ

  • Z

    Zou, Yang

    shenyang pharmaceut univ

  • M

    Ma, Ruixin

    shenyang pharmaceut univ

  • G

    Gu, Yanting

    shenyang pharmaceut univ

  • H

    Huang, Jian

    harbin med univ

  • L

    Li, Songping

    shenyang pharmaceut univ

  • W

    Wang, Jinhui

    harbin med univ

  • W

    Wang, Jiahong

    shenyang pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417